Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
02 2020
Historique:
received: 05 04 2019
accepted: 01 11 2019
entrez: 7 2 2020
pubmed: 7 2 2020
medline: 6 5 2020
Statut: epublish

Résumé

Most HIV-1 infected individuals do not know their infection dates. Precise infection timing is crucial information for studies that document transmission networks or drug levels at infection. To improve infection timing, we used the prospective RV217 cohort where the window when plasma viremia becomes detectable is narrow: the last negative visit occurred a median of four days before the first detectable HIV-1 viremia with an RNA test, referred below as diagnosis. We sequenced 1,280 HIV-1 genomes from 39 participants at a median of 4, 32 and 170 days post-diagnosis. HIV-1 infections were dated by using sequence-based methods and a viral load regression method. Bayesian coalescent and viral load regression estimated that infections occurred a median of 6 days prior to diagnosis (IQR: 9-3 and 11-4 days prior, respectively). Poisson-Fitter, which analyzes the distribution of hamming distances among sequences, estimated a median of 7 days prior to diagnosis (IQR: 15-4 days) based on sequences sampled 4 days post-diagnosis, but it did not yield plausible results using sequences sampled at 32 days. Fourteen participants reported a high-risk exposure event at a median of 8 days prior to diagnosis (IQR: 12 to 6 days prior). These different methods concurred that HIV-1 infection occurred about a week before detectable viremia, corresponding to 20 days (IQR: 34-15 days) before peak viral load. Together, our methods comparison helps define a framework for future dating studies in early HIV-1 infection.

Identifiants

pubmed: 32027734
doi: 10.1371/journal.ppat.1008179
pii: PPATHOGENS-D-19-00628
pmc: PMC7004303
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1008179

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Mol Biol Evol. 2017 Mar 1;34(3):772-773
pubmed: 28013191
Syst Biol. 2011 Mar;60(2):150-60
pubmed: 21187451
J Virol. 2010 Oct;84(19):10406-12
pubmed: 20686016
Bioinformatics. 2017 Mar 15;33(6):932-934
pubmed: 28365756
PLoS Pathog. 2016 May 10;12(5):e1005619
pubmed: 27163788
Nat Med. 2017 Feb;23(2):185-191
pubmed: 28092665
J Virol. 2011 Aug;85(15):7523-34
pubmed: 21593162
Virus Evol. 2019 Nov 04;5(2):vez044
pubmed: 31700680
J Infect Dis. 2010 Oct 15;202 Suppl 2:S270-7
pubmed: 20846033
Viruses. 2019 Jul 03;11(7):
pubmed: 31277299
Am J Med. 1997 May 19;102(5B):117-24; discussion 125-6
pubmed: 9845513
AIDS Res Hum Retroviruses. 2017 May;33(5):410-423
pubmed: 28006952
N Engl J Med. 2016 Jun 2;374(22):2120-30
pubmed: 27192360
Adv Parasitol. 2003;54:331-58
pubmed: 14711090
Science. 2014 Sep 12;345(6202):1369-72
pubmed: 25214632
Clin Infect Dis. 2017 Jan 1;64(1):53-59
pubmed: 27737954
Infect Genet Evol. 2013 Aug;18:125-31
pubmed: 23583545
BMC Bioinformatics. 2015 Nov 04;16:355
pubmed: 26538192
Mol Biol Evol. 2013 Feb;30(2):239-43
pubmed: 23090976
J Infect Dis. 2012 Aug 1;206(3):431-41
pubmed: 22634875
Syst Biol. 2016 Jan;65(1):82-97
pubmed: 26424727
AIDS. 2003 Sep 5;17(13):1871-9
pubmed: 12960819
PLoS Biol. 2006 May;4(5):e88
pubmed: 16683862
AIDS Rev. 2006 Jul-Sep;8(3):125-40
pubmed: 17078483
J Virol. 2008 Apr;82(8):3952-70
pubmed: 18256145
Mol Biol Evol. 1988 Jul;5(4):313-30
pubmed: 3405075
PLoS One. 2016 Aug 23;11(8):e0160649
pubmed: 27552218
Mol Biol Evol. 2012 Aug;29(8):1969-73
pubmed: 22367748
Nature. 2017 Jun 15;546(7658):406-410
pubmed: 28538727
Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10752-7
pubmed: 10485898
Nat Rev Immunol. 2010 Jan;10(1):11-23
pubmed: 20010788
Vaccine. 2016 Nov 11;34(47):5792-5801
pubmed: 27756485
BMC Biol. 2010 Aug 31;8:114
pubmed: 20807414
AIDS. 2011 Oct 23;25(16):2047-8
pubmed: 21997490
Lancet. 2004 Feb 21;363(9409):619-22
pubmed: 14987889
J Exp Med. 2009 Jun 8;206(6):1253-72
pubmed: 19487423
Bioinformatics. 2016 Jul 1;32(13):1933-42
pubmed: 27153688
N Engl J Med. 2016 Nov 24;375(21):2037-2050
pubmed: 27959728
Epidemics. 2017 Sep;20:73-83
pubmed: 28365331
J Clin Microbiol. 2014 Jan;52(1):115-21
pubmed: 24153134
Sci Transl Med. 2015 Dec 23;7(319):319ra206
pubmed: 26702094
Science. 2000 Jun 9;288(5472):1789-96
pubmed: 10846155
BMC Bioinformatics. 2010 Oct 25;11:532
pubmed: 20973976
AIDS. 2011 Oct 23;25(16):F13-9
pubmed: 21716075
Science. 2014 Oct 3;346(6205):56-61
pubmed: 25278604
Biotechniques. 2010 May;48(5):405-8
pubmed: 20569214
Nature. 2012 Oct 18;490(7420):417-20
pubmed: 22960785
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Syst Biol. 2016 May;65(3):495-507
pubmed: 26658901
PLoS One. 2011 May 10;6(5):e19617
pubmed: 21573003
Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7
pubmed: 18490657
PLoS Comput Biol. 2017 Oct 2;13(10):e1005775
pubmed: 28968389
J Virol. 2010 Jun;84(12):6096-102
pubmed: 20357090
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
AIDS. 2011 Oct 23;25(16):2019-26
pubmed: 21832936
Mol Biol Evol. 2005 May;22(5):1185-92
pubmed: 15703244
J Virol. 2009 Apr;83(8):3556-67
pubmed: 19193811
J Clin Microbiol. 2014 Aug;52(8):2977-83
pubmed: 24920768
Mucosal Immunol. 2012 Jan;5(1):41-52
pubmed: 22031182
Nat Med. 2011 Mar;17(3):366-71
pubmed: 21358627
Virus Evol. 2017 Mar 02;3(1):vex003
pubmed: 28458914
PLoS One. 2017 Nov 17;12(11):e0185959
pubmed: 29149197
Bioinformatics. 2004 Jan 22;20(2):289-90
pubmed: 14734327
J Exp Med. 2009 Jun 8;206(6):1273-89
pubmed: 19487424
N Engl J Med. 1998 Jul 2;339(1):33-9
pubmed: 9647878
Mol Biol Evol. 2012 Sep;29(9):2157-67
pubmed: 22403239
J Theor Biol. 2010 Dec 7;267(3):396-404
pubmed: 20851708
J Infect Dis. 2012 Sep 1;206(5):756-64
pubmed: 22826337
J Theor Biol. 2009 Nov 21;261(2):341-60
pubmed: 19660475

Auteurs

Morgane Rolland (M)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

Sodsai Tovanabutra (S)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

Bethany Dearlove (B)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

Yifan Li (Y)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

Christopher L Owen (CL)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

Eric Lewitus (E)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

Eric Sanders-Buell (E)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

Meera Bose (M)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

AnneMarie O'Sullivan (A)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

Raabya Rossenkhan (R)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.

Jan Phillipus Lourens Labuschagne (JPL)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.

Paul T Edlefsen (PT)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.

Daniel B Reeves (DB)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.

Gustavo Kijak (G)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

Shana Miller (S)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

Kultida Poltavee (K)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

Jenica Lee (J)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

Lydia Bonar (L)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

Elizabeth Harbolick (E)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

Bahar Ahani (B)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

Phuc Pham (P)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

Hannah Kibuuka (H)

Makerere University Walter Reed Project, Kampala, Uganda.

Lucas Maganga (L)

National Institute for Medical Research-Mbeya Medical Research Center, Mbeya, Tanzania.

Sorachai Nitayaphan (S)

Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.

Fred K Sawe (FK)

Kenya Medical Research Institute/U.S. Army Medical Research Directorate-Africa/Kenya-Henry Jackson Foundation MRI, Kericho, Kenya.

Leigh Anne Eller (LA)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

Robert Gramzinski (R)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.

Jerome H Kim (JH)

International Vaccine Institute, Seoul, South Korea.

Nelson L Michael (NL)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

Merlin L Robb (ML)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH